Hepatitis B virus-related liver cirrhosis complicated with dermatomyositis: A case report

Table 2 A case reviews of dermatomyositis associated with hepatocellular carcinoma since 2000

Ref.	Published yr	Age / Sex	Virus infection	Associated disorders	Autoantibody profile	Treatment	Outcome
Cheng et al[21]	2002	50/F	HBV	Erythrocytosis	ND	Steroid, TACE, Hepatectomy	Died
Inuzuka et al[22]	2001	51/M	HCV	Acquired ichthyosis	ANA(+), Anti-Jo-1(-)	Steroid	Died
Kee et al[11]	2004	71/M	HCV	-	ANA(+), Anti-Jo-1(-)	Steroid	ND
Toshikuni et al[23]	2006	79/F	HCV	-	ANA(+), RF(-), Anti-Jo-1 (-)	Steroid, TACE	Died
Kee et al[13]	2009	58/M	HBV	-	ANA(+), RF(-), Anti-Jo-1 (-)	Steroid, IVIG, TACE	Died
Yang et al[14]	2014	55/M	HBV	-	ANA(+), Anti-Jo-1(-)	Lamivudine, Steroid	Died
Han et al[9]	2018	62/M	HBV	-	ANA(+), Anti-Jo-1(-), Anti-Mi2(-)	Steroid, Entecavir, Radio- frequency ablation	Died

ND: Not described; F: Female; M: Male; ANA: Antinuclear antibody; RF: Rheumatoid factor; TACE: Transarterial chemoembolization; IVIG: Intravenous immunoglobulin; HBV: Hepatitis B virus; HCV: Hepatitis C virus.